Search
for
Sort by
Research 331–360 of 777
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Small molecules and small molecule drugs in regenerative medicine
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Alopecia Areata and Alopecia Areata Incognita
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- The orchestrated network of skin photoaging: From intercellular crosstalk to molecular signaling
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Hidradenitis suppurativa: a new therapeutic approach for an old disease
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Androgenetic Alopecia: Therapy Update
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- The role of lymphocytes in the development and treatment of alopecia areata
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- Emerging treatments in alopecia
- Molecular pathology of skin adnexal tumours
- MSC-EVs and UCB-EVs promote skin wound healing and spatial transcriptome analysis
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- An updated review of the sebaceous gland and its role in health and diseases Part 2: Pathophysiological clinical disorders of sebaceous glands
- Janus kinase inhibitors for alopecia areata: a review of clinical data